Skip navigation

Currently Being Moderated

the pneumococcal vaccine

Posted by bonnie2922 on Dec 13, 2010 12:27:34 AM

Millions of babies and children could soon be protected against the  deadly disease pneumonia. Two leading drug companies have agreed to  supply vaccines against pneumococcal disease to the world's poorest  countries at a reduced price. Pfizer and GlaxoSmithKline signed the  historic Advance Market Commitment agreement last week. The Global  Alliance for Vaccines and Immunizations, or GAVI, helped negotiate the  deal. The group says the low cost vaccines could save as many as seven  million lives by the year twenty thirty.

The World Health Organization says pneumonia kills almost two million  children each year.p90x cheap This is more than AIDS, malaria and measles  combined. It is the leading cause of death among young children. And,  more than ninety percent of those deaths happen in the developing world.

These are all reasons why GAVI chose the pneumococcal vaccine for its  first Advance Market Commitment proje  p90x workouthe private-public  partnerships are designed to increase the availability of low cost  vaccines in poor areas.

Last year, the governments of Italy, the United Kingdom, Canada,  Russia and Norway joined with the Bill and Melinda Gates Foundation.  They provided one and a half billion dollars to launch the pneumococcal  vaccine project. Jeffrey Rowland is with the GAVI alliance. He says the  money helps to persuade drug makers to take part in the project.

JEFFREY ROWLAND: "The biggest challenge of getting life saving  vaccines to poor countries is that there's no market. rosetta stone spanish People can't  afford them. That's why we don't really have a malaria vaccine yet,  because no one in rich countries really suffers from malaria.rosetta stone french What we  did for the pneumococcal vaccine was we said we will pay one point five  billion dollars if you develop the right vaccines, and the right volumes  that we need and at the right price. And it was a gamble."

That gamble paid off. GlaxoSmithKline and Pfizer have agreed to  provide thirty million doses of the vaccine each year for ten years. The  first twenty percent of the vaccines will sell for seven dollars a  dose. The remaining eighty percent will cost three dollars and fifty  cents per dose. That is ninety per cent less than current prices in the  United States.

Mister Rowland says the agreement is a huge achievement for the developing world.

Comments (0)